In line with these data, USP10 influenced the prognosis of HCC patients, as the progression‐free survival (PFS) significantly decreases in hepatitis virus‐related HCC patients harboring higher levels of USP10 (Menyhart et al., 2018) (http://kmplot.com/analysis/index.php?p =service&cancer=liver_rnaseq and http://kmplot.com/analysis/index.php?p=service&start=1) (Fig. S2B). This evidence concerns the gene USP10 and hepatocellular carcinoma.